News | TCTAP 2022
News TCTAP
News | TCTAP 2022
‘Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy’
Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones
News | TCTAP 2022
Tailored de-escalation strategy in PCI and ACS: platelet function test and genetic test guidance
At TCTAP 2022, Dominick J. Angiolillo, MD outlines de-escalation strategies with PFT, genetic tests for PCI-ACS
News | TCTAP 2022
Can PCI save lives in severe LV dysfunction?
Divaka Perera, MD says REVIVED-BCIS2 to shed light on revascularization decisions for acute and chronic LV dysfunction
News | TCTAP 2022
Real issue in CABG vs PCI for left main? 'Balancing 'hard' outcomes with patient preferences'
Brian Bergmark, MD addresses real-life implications of meta-analysis that showed no mortality difference between PCI-CABG at TCTAP 2022
ISSN: 3058-6437 | 간행물등록번호: 송파,마00061 | 등록일자: 2024년 10월 10일 | 발행인/편집인: 박승정